AI English summary of an SEC filing — figures as filed
The company said it appointed Prem S. Shah as Executive Vice President and Group President, a newly created position, on November 6, 2024, and the appointment took effect the same day, according to the press release.
Key points
AI summaryThe company said it appointed Prem S. Shah as Executive Vice President and Group President, a newly created position, on November 6, 2024, and the appointment took effect the same day, according to the press release.
CVS Health said the Group President will be responsible for the operational performance and integrated value creation of CVS Caremark, CVS Pharmacy and the Health Care Delivery businesses, including Oak Street Health and Signify Health.
The company said Shah, age 44, has served as Executive Vice President, Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness since January 2023, and was Executive Vice President of CVS Specialty from June 2018 to November 2022.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call. Some paragraphs were omitted because their support in the source could not be confirmed.
Prem S. Shah Appointed to Newly Created Group President Role
The company said it appointed Prem S. Shah as Executive Vice President and Group President, a newly created position, on November 6, 2024, and the appointment took effect the same day, according to the press release.
Source · Based on the filing body and exhibits
Scope of Group President Role
CVS Health said the Group President will be responsible for the operational performance and integrated value creation of CVS Caremark, CVS Pharmacy and the Health Care Delivery businesses, including Oak Street Health and Signify Health.
Source · Based on the filing body and exhibits
Shah's Prior Positions and Experience
The company said Shah, age 44, has served as Executive Vice President, Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness since January 2023, and was Executive Vice President of CVS Specialty from June 2018 to November 2022.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…